Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis [2]

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 1, 2006, Pages 148-149

  Kamis, Umit ^a   Ozturk, Banu T ^a   Ozkagnici, Ahmet ^a   Gunduz, Kemal ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ARTIFICIAL TEAR; HISTAMINE H1 RECEPTOR; OLOPATADINE; TEARS NATURALE II;

ADOLESCENT; ADULT; CHEMOSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; ENVIRONMENTAL EXPOSURE; EYELID EDEMA; FEMALE; HUMAN; LACRIMATION; LETTER; MAJOR CLINICAL STUDY; MALE; OCULAR PRURITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SCORING SYSTEM; SEASONAL ALLERGIC CONJUNCTIVITIS; SLIT LAMP; SPECTACLES; TREATMENT OUTCOME; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CONJUNCTIVITIS, ALLERGIC; DIBENZOXEPINS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33644778792     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00620.x     Document Type: Letter

References (6)

1. Abelson MB (1998): Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann Allergy Asthma Immunol 81: 211-218.
2. Abelson MB & Spitalny L (1998): Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine, a new ophthalmic antiallergic agent with dual activity. Am J Ophthalmol 125: 797-804.
3. Bielory L (2000): Allergic and immunologic disorders of the eye. Part II. Ocular allergy. J Allergy Clin Immunol 106: 1019-1032.
4. Leonardi A & Zafirakis P (2004): Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: A double-masked, environmental study of patient preference. Curr Med Res Opin 20: 1167-1173.
5. Spangler DL, Bensch G & Berdy GJ (2001): Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. Clin Ther 23: 1272-1280.
6. Yaylali V, Demirlenk I, Tatlipinar S, Özbay D, Esme A, Yildiirm C & Özden S (2003): Comparative study of 0.1% olopatadine hydrochloride and ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis. Acta Ophthalmol Scand 81: 378-382.